Stock 2315 BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Equities

2315

CNE100005D27

End-of-day quote Hong Kong S.E.
Other stock markets
 23:00:00 13/06/2024 BST 		5-day change 1st Jan Change
8.07 CNY +0.25% Intraday chart for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. +0.50% -32.64%
06-04 XtalPi Inc. announced that it has received CNY 337 million in funding from Shanghai Guosheng Investment Group, Biocytogen Pharmaceuticals Co., Ltd., FaaS Capital Longevity Limited and other investors CI
05-06 Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Other Biotechnology & Medical Research
+0.25%+0.50%-32.64%-62.11% - 413M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 2315 Stock
  4. Charts Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW